A field-tested LOI framework built for behavioral health acquisitions — covering clinician retention earnouts, credentialing contingencies, payer contract assumptions, and HIPAA compliance protections specific to outpatient therapy and counseling practices.
A Letter of Intent (LOI) for a mental health private practice acquisition is far more nuanced than a standard business LOI. The value of the practice depends heavily on licensed clinicians staying post-close, insurance credentialing transferring cleanly, and the seller remaining available to transition client relationships and referral networks. For buyers — whether PE-backed behavioral health platforms, regional group practices, or individual clinician-operators — the LOI must address provider retention risk, payer contract continuity, and state corporate practice of medicine (CPOM) restrictions before due diligence begins. For sellers — therapists, psychologists, and counselors looking to exit or transition to clinical-only roles — the LOI sets the stage for how purchase price is structured, how earnout milestones are calculated, and whether your clinical staff and clients will be protected through the transition. This guide and template walk through every material section of a behavioral health practice LOI, with example language and negotiation notes drawn directly from lower middle market mental health acquisitions in the $750K–$4M revenue range.
Find Mental Health Private Practice Businesses to AcquireParties and Practice Description
Identifies the buyer entity, the seller (individual clinician-owner or practice entity), and provides a precise description of what is being acquired — the legal practice entity, DBA names, clinical service lines, and physical or virtual practice locations.
Example Language
This Letter of Intent is entered into by [Buyer Entity Name], a [State] [LLC/Corporation] ('Buyer'), and [Seller Name / Practice Entity Name], a [State] [PLLC/PC/LLC] ('Seller'), operating as [DBA Name if applicable], located at [Address] and providing outpatient individual, group, and/or telehealth therapy services through [#] licensed clinicians across [#] locations. Buyer intends to acquire substantially all assets of the practice, including client records (subject to HIPAA-compliant transfer protocols), payer contracts, EHR system access, lease rights, and goodwill, subject to terms herein.
💡 Sellers should confirm the buyer entity is properly structured to own a behavioral health practice in the relevant state — many states with CPOM restrictions require the buyer to be a licensed clinician or a management services organization (MSO) structure. Buyers should specify asset purchase vs. entity purchase at this stage, as asset purchases are strongly preferred in mental health acquisitions to avoid assuming unknown liability including billing audit exposure, prior HIPAA violations, or malpractice claims.
Purchase Price and Valuation Basis
States the proposed total enterprise value, the basis for valuation (typically a multiple of EBITDA or Seller's Discretionary Earnings), and any adjustments for working capital, accounts receivable, or deferred revenue.
Example Language
Buyer proposes a total purchase price of $[X], representing approximately [3.5x–5x] trailing twelve-month EBITDA of $[X], as reported in Seller's most recent fiscal year financials and preliminary quality of earnings review. The purchase price is allocated as follows: $[X] in cash at closing, $[X] in a seller note amortized over [24–36] months at [6–7]% interest, and up to $[X] in performance-based earnout payments as described in Section [X]. Accounts receivable outstanding at closing shall remain with Seller unless otherwise agreed. Working capital target shall be defined during due diligence.
💡 Mental health practice EBITDA multiples in the lower middle market typically range from 3x to 5.5x, with premium pricing for practices showing consistent revenue growth, diversified payer mix, and a multi-clinician team with low owner-revenue concentration. Sellers should push back on any valuation that applies a heavy discount solely for Medicaid concentration without reviewing actual audit history. Buyers should verify that stated EBITDA adds back owner compensation at market replacement cost — many solo and small group practice owners pay themselves below-market salaries, inflating reported EBITDA.
Earnout Structure Tied to Clinician Retention and Revenue
Defines the earnout milestones, measurement periods, and payout triggers linked to clinician retention, client retention, and revenue performance post-acquisition — the most critical and contested section in any behavioral health LOI.
Example Language
Buyer shall pay Seller an earnout of up to $[X] over a [12–24]-month period following closing, contingent upon the following milestones: (1) At least [80%] of licensed clinicians currently employed or contracted by the practice remain actively seeing clients through Month 12 post-close; (2) Total practice collections equal or exceed $[X] during the earnout period, measured on a trailing 12-month basis; (3) No material payer contract terminations reducing aggregate in-network reimbursement by more than [15%]. Earnout payments shall be made [quarterly/annually] within [30] days of each measurement date. Buyer shall not materially alter clinician compensation structures or working conditions during the earnout period without Seller's written consent.
💡 Earnouts tied to clinician retention are standard in behavioral health deals because clinician departure is the single largest source of value destruction post-close. Sellers should negotiate hard for the earnout measurement methodology to be transparent and auditable, with Buyer obligated to provide monthly collections reports. Buyers should ensure the earnout does not inadvertently reward Seller for clinician performance that Buyer's own operational improvements drove. Both parties should agree on what constitutes an 'involuntary' clinician departure — if Buyer terminates a clinician without cause, that should not count against the Seller's earnout threshold.
Due Diligence Scope and Access
Outlines the specific due diligence items Buyer requires access to, the timeline for completing due diligence, and the confidentiality obligations governing clinician and client information.
Example Language
Seller agrees to provide Buyer with access to the following materials within [15] business days of LOI execution: (1) Three years of financial statements, tax returns, and monthly P&L reports; (2) All clinician employment agreements, independent contractor agreements, compensation schedules, and non-solicitation or non-compete agreements; (3) Payer credentialing files, current panel status, and copies of all insurance contracts; (4) EHR system access for operational review (client records to be reviewed in de-identified format only, consistent with HIPAA); (5) Lease agreements for all office locations; (6) Billing and collections reports including accounts receivable aging, denial rates, and average reimbursement by payer; (7) Documentation of HIPAA compliance policies, business associate agreements, and any prior audit findings or breach notifications; (8) State licensure records for all billable clinicians and documentation of any supervisory relationships. Due diligence period shall run for [45–60] days from receipt of complete materials.
💡 HIPAA is a non-negotiable constraint on due diligence access — Buyer cannot review identifiable client records without a proper legal framework in place. Buyers should engage a healthcare attorney immediately upon LOI execution to structure compliant data access. Sellers should ensure that any EHR or billing system access granted is logged and limited in scope. The clinician employment agreements and non-solicitation provisions are often the most revealing documents — buyers should treat any practice where key clinicians have no written agreements as a significant red flag requiring price adjustment or enhanced retention provisions.
Exclusivity and No-Shop Period
Grants Buyer an exclusive negotiating period during which Seller may not solicit, entertain, or advance discussions with other potential acquirers.
Example Language
In consideration of Buyer's investment of time and resources in due diligence, Seller agrees to a [45]-day exclusivity period commencing upon full execution of this LOI, during which Seller shall not solicit, initiate, or respond to acquisition inquiries from third parties. Exclusivity may be extended by mutual written agreement for up to an additional [15] days if due diligence is substantially complete but definitive agreement negotiation remains ongoing.
💡 Sellers should resist exclusivity periods longer than 45–60 days unless Buyer has demonstrated serious financing capability (e.g., SBA 7(a) prequalification letter, evidence of equity capital). Behavioral health practice sales often move slowly due to credentialing and regulatory complexity, and a long exclusivity period without a committed buyer wastes valuable time. Buyers should use the exclusivity period productively — begin SBA loan processing, engage a healthcare-specific M&A attorney, and initiate credentialing transfer research immediately rather than waiting for the exclusivity clock to run out.
Financing Contingency
Specifies whether the LOI and subsequent purchase are contingent on Buyer securing financing, including SBA 7(a) loan approval, and the timeline for obtaining a commitment.
Example Language
This LOI and Buyer's obligations hereunder are contingent upon Buyer obtaining a financing commitment for no less than $[X] in the form of an SBA 7(a) loan, conventional bank financing, or private equity capital, within [30] days of LOI execution. Buyer shall provide Seller with a lender pre-qualification letter or commitment letter within said period. If financing commitment is not obtained within [30] days, either party may terminate this LOI without further obligation, provided Buyer has made commercially reasonable efforts to secure financing.
💡 SBA 7(a) loans are the most common financing vehicle for lower middle market mental health practice acquisitions, typically covering 75–85% of purchase price with a 10-year term. Sellers should request evidence of SBA pre-qualification — not just a lender introduction — before granting exclusivity. Buyers should note that SBA lenders will conduct their own quality of earnings review and may require a physician/clinician practice management company structure review. Practices with heavy Medicaid concentration or undocumented HIPAA compliance may face SBA lender hesitation.
Seller Transition and Post-Close Role
Describes the seller's expected post-closing involvement, including clinical work, client transition support, staff communication responsibilities, and any consulting or employment arrangement.
Example Language
Seller agrees to remain available to Buyer for a transition period of [6–12] months following closing in the capacity of [Clinical Director / Senior Therapist / Transition Consultant] at a compensation of $[X] per [month/hour], during which Seller shall: (1) continue seeing existing clients as mutually agreed; (2) personally introduce Buyer or Buyer's designated clinical leadership to key referral partners; (3) communicate the ownership transition to staff and, where clinically appropriate, to clients; and (4) cooperate with payer credentialing and contract assignment processes. Seller's post-close clinical caseload, if any, shall not exceed [X] clients per week.
💡 This section is often emotionally charged for seller-clinicians who have built a practice over many years. Buyers should frame the transition role as a value-protection mechanism for clients and staff — not as a monitoring arrangement. Sellers should negotiate for clarity on compensation during the transition period and push to define what 'transition complete' looks like so they have a defined offramp. For earnout-linked deals, the transition role duration should align with the earnout measurement period to ensure Seller has operational visibility into what's driving revenue performance.
Representations and Conditions to Closing
High-level representations that Seller makes regarding the accuracy of financial information, clinician licensure, HIPAA compliance, and absence of material pending litigation or regulatory action.
Example Language
As a condition to Buyer's obligation to proceed to definitive agreement and closing, Seller represents and warrants that: (1) All financial statements provided are accurate and prepared in conformity with cash or accrual basis accounting consistently applied; (2) All clinicians are currently licensed and in good standing with their respective state licensing boards; (3) The practice has no pending or threatened malpractice claims, regulatory investigations, CMS or state Medicaid audits, or HIPAA breach notifications not previously disclosed; (4) All payer contracts are current, in good standing, and not subject to pending termination; (5) The practice is not in violation of any state corporate practice of medicine or fee-splitting prohibitions. These representations shall survive closing and be incorporated into the definitive purchase agreement.
💡 Sellers should disclose any open billing audits, prior HIPAA incidents, or licensing board inquiries proactively at the LOI stage — concealing these and having them discovered during due diligence is a deal-killer that will also damage negotiating leverage on price. Buyers should treat any undisclosed billing irregularities or Medicaid audit exposure as a significant risk requiring escrow or price reduction at minimum. State CPOM review is essential — in states like Texas, California, and New York, ownership structures must be carefully designed to avoid fee-splitting violations.
Confidentiality
Mutual agreement to keep the terms of the LOI, due diligence materials, and the existence of the transaction confidential from staff, clients, payers, and competitors.
Example Language
Both parties agree to maintain strict confidentiality regarding the existence and terms of this LOI and all due diligence materials exchanged hereunder. Seller shall not disclose the potential transaction to clinicians, administrative staff, insurance payers, or referral sources without Buyer's prior written consent, and Buyer shall not contact Seller's clinicians, staff, referral sources, or payers directly without Seller's prior written consent. A mutual NDA executed prior to this LOI shall remain in full force and effect.
💡 Confidentiality is especially sensitive in mental health practices because staff anxiety about ownership changes is a leading driver of clinician turnover — the primary risk in any behavioral health acquisition. Buyers should never approach clinicians directly during due diligence without Seller present or explicitly consenting. Both parties should agree on a joint communication plan for staff disclosure before closing, not after, to manage culture and retention risk proactively.
Clinician Retention Earnout Thresholds and Measurement Methodology
The percentage of clinicians required to remain active post-close, the definition of 'active' (minimum client hours per week), the measurement dates, and what happens if Buyer's own decisions cause clinician departures should all be explicitly defined. This is the highest-stakes negotiating point in any behavioral health LOI and directly determines how much of the total purchase price the Seller will actually receive.
Owner-Clinician Revenue Concentration Adjustment
If the selling clinician treats more than 30% of active clients, buyers typically apply a valuation discount or increase earnout dependency. Sellers should negotiate for a longer transition period and higher base payment to reflect the reality that client relationships can be transferred over time with proper clinical handoff protocols — not eliminated entirely.
Accounts Receivable Treatment and Working Capital Target
Behavioral health practices often carry significant AR from insurance claims in various stages of processing. Buyers and sellers must agree on whether AR stays with the seller, is purchased at a discount, or is included in the purchase price at face value. The working capital peg should be set based on a trailing average to avoid penalizing sellers for normal billing cycle timing.
Credentialing and Payer Contract Transfer Contingency
Insurance credentialing for new ownership can take 60–180 days and cannot always be guaranteed. LOIs should include a condition requiring that credentialing transfer for key payers covering at least a defined percentage of revenue (e.g., 75%) be initiated within a specified period post-LOI, with closing contingent on receiving at least preliminary approval from major commercial payers.
Non-Solicitation vs. Non-Compete Scope for Seller-Clinician
Post-close restrictions on the selling clinician must balance buyer's legitimate interest in protecting client relationships and staff against seller's clinical career rights. Non-solicitation of clients and staff for 24 months in the local market is generally enforceable; non-compete provisions that prevent a clinician from practicing their licensed profession entirely are frequently challenged. Sellers should resist broad non-competes and push for narrowly defined non-solicitation language with geographic limits tied to actual service area.
HIPAA-Compliant Client Record Transfer Protocol
The LOI should acknowledge that client records transfer is subject to HIPAA and applicable state mental health privacy laws, and that clients will be notified of the ownership change in a manner consistent with their rights. Sellers should ensure the buyer has a signed BAA in place and a clear data governance plan before any EHR access is granted during due diligence.
State Corporate Practice of Medicine Structure Requirements
In CPOM-restricted states, the acquisition structure may require a licensed clinician to nominally own the clinical entity while a management services organization (MSO) owned by the buyer controls operations. This structure must be reflected in the LOI's description of the proposed transaction structure, and both parties should engage healthcare legal counsel before the LOI is finalized to avoid structuring the deal in a way that cannot legally close.
Find Mental Health Private Practice Businesses to Acquire
Enough information to write a strong LOI on day one — free to join.
Most lower middle market mental health practices are valued at 3x to 5.5x EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization), with practices at the higher end of the multiple range demonstrating a multi-clinician team with low owner-revenue concentration, consistent year-over-year revenue growth, a diversified payer mix weighted toward commercial insurance and private pay, and clean billing and HIPAA records. Practices where the owner-clinician treats more than 30–40% of clients, carries heavy Medicaid concentration, or has undocumented operations typically trade at 3x–3.5x or lower. The LOI should specify both the EBITDA figure being used and the trailing period (typically the most recent 12 months) to avoid valuation disputes during due diligence.
Three things make mental health LOIs structurally distinct. First, the earnout is clinician-retention dependent — because licensed therapists and psychologists are the revenue-generating asset, the purchase price is almost always partially contingent on key clinicians staying post-close, which requires specific retention threshold language that is not present in most other business acquisitions. Second, HIPAA governs what due diligence can access — client records, clinical notes, and billing data are subject to federal and state privacy law, and the LOI must acknowledge a compliant framework for data access. Third, state corporate practice of medicine laws may dictate the legal ownership structure of the deal, and if these restrictions are not addressed in the LOI, the parties may spend weeks negotiating a structure that cannot legally close in their state.
Asset purchase is strongly preferred by buyers in behavioral health acquisitions and is the structure used in the vast majority of lower middle market mental health deals. An asset purchase allows the buyer to acquire client relationships, payer contracts, EHR data, goodwill, and physical assets while leaving behind the seller entity's historical liabilities — including prior billing errors, undisclosed HIPAA incidents, malpractice claims, and CMS audit exposure. Entity purchases (buying the LLC or PLLC itself) are occasionally used when payer contract assignment is difficult and keeping the existing entity in place simplifies credentialing continuity, but this must be weighed carefully against the liability assumption risk. Healthcare legal counsel should advise on this decision before the LOI is signed.
The LOI should include an explicit credentialing contingency stating that closing is conditional on Buyer receiving credentialing approval or a credentialing-in-process status from payers representing at least a defined threshold of practice revenue — typically 70–80%. Both parties should acknowledge in the LOI that credentialing timelines are controlled by payers and may take 60–180 days, and should agree to a process for managing revenue continuity during any credentialing gap period. Options include keeping the Seller entity active and billing under existing credentials through a transition services agreement, or having Buyer engage a billing and credentialing specialist immediately upon LOI execution to minimize delays. This is one of the most common sources of deal disruption in behavioral health acquisitions and should not be left to the definitive purchase agreement stage.
Most behavioral health LOIs include a post-close transition arrangement for the selling clinician covering 6 to 18 months. The specific role varies — some sellers transition to a part-time clinical director role, others reduce to a limited clinical caseload while introducing the buyer to referral partners and staff, and some exit clinical work entirely but remain available as a consultant. What matters most from the LOI perspective is that the transition role is defined with specificity: compensation structure, expected hours, client caseload cap, referral introduction obligations, and an explicit end date or offramp. Sellers who leave the transition role open-ended often find themselves performing de facto management work without compensation, while buyers who fail to plan the transition role lose the institutional knowledge and relationship capital that drives earnout performance.
More Mental Health Private Practice Guides
More LOI Templates
Get enough diligence data to write a confident LOI from day one.
Create your free accountNo credit card required
For Buyers
For Sellers